Emerging issues in blood safety

Infectious Disease Clinics of North America

Volumn 12, Issue 1, 1998, Pages 217-229

  Chamberland, M ^a   Khabbaz, R F ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHAGAS DISEASE; CREUTZFELDT JAKOB DISEASE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION CONTROL; INFECTION RISK; PARVOVIRUS; PRION DISEASE; REVIEW; SAFETY; UNITED STATES; VIRUS INACTIVATION; VIRUS TRANSMISSION;

EID: 0031894711     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70419-0     Document Type: Article

References (84)

1. H.J. Alter R.H. Purcell P.V. Holland Clinical and serological analysis of transfusion-associated hepatitis Lancet 2 1975 838
2. H.J. Alter Y. Nakatsuji J. Melpolder The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease N Engl J Med 336 1997 747
3. H.J. Alter G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus [editorial] Transfusion 37 1997 569
4. M.J. Alter S.C. Hadler F.J. Judson Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection JAMA 264 1990 2231
5. M.J. Alter H.S. Margolis K. Krawczynski The natural history of community-acquired hepatitis C in the United States N Engl J Med 327 1992 1899
6. M.J. Alter Residual risk of transfusion-associated hepatitis. NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions 1995 National Institutes of Health Bethesda 23
7. M.J. Alter M. Gallagher T. Morris Acute non-A–E hepatitis in the United States and the role of hepatitis G virus infection N Engl J Med 336 1997 741
8. J.P. AuBuchon Blood transfusion options: Improving outcomes and reducing costs Arch Pathol Lab Med 121 1997 40
9. S.J. Badon R.D. Fister R.G. Cable Survival of Borrelia burgdorferi in blood products Transfusion 29 1989 581
10. B.B. Barrett J.W. Andersen K.C. Anderson Strategies for the avoidance of bacterial contamination of blood components Transfusion 33 1993 228
11. M.A. Blajchman Transfusion-associated bacterial sepsis: The phoenix rises yet again Transfusion 34 1994 940
12. D.J. Blackbourn J. Ambroziak E. Lennette Infectious human herpesvirus 8 in a healthy North American blood donor Lancet 349 1997 609
13. R.J. Brashear M.A. Winkler J.D. Schur Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I: Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi Transfusion 35 1995 213
14. J.S. Bresee E.E. Mast P.J. Coleman Hepatitis C virus infection associated with administration of intravenous immune globulin: A cohort study JAMA 276 1996 1563
15. P. Brown Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol 2 1995 472
16. M.P. Busch L.L.L. Lee G.A. Satten Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors Transfusion 35 1995 91
17. M.P. Busch S.A. Glynn G.B. Schreiber Increased risk of viral transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease Transfusion 37 1997 996
18. Centers for Disease Control Human T-lymphotropic virus type I screening in volunteer blood donors: United States, 1989 MMWR 39 1990 915
19. Centers for Disease Control Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C MMWR 40 RR-4 1991 1
20. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices MMWR 45 RR-15 1996 1
21. Centers for Disease Control and Prevention Identification of HIV-1 group O infection: Los Angeles County, California, 1996 MMWR 45 1996 561
22. Centers for Disease Control and Prevention Bacterial sepsis associated with receipt of albumin MMWR 45 1996 866
23. Centers for Disease Control and Prevention Red blood cell transfusions contaminated with Yersinia enterocolitica : United States, 1991–1996, and initiation of a national study to detect bacteria-associated transfusion reactions MMWR 46 1997 553
24. Z. Davanipour M. Alter E. Sobel A case-control study of Creutzfeldt-Jakob disease. Dietary risk factors Am J Epidemiol 122 1985 443
25. S.J. DeArmond S.P. Prusiner Etiology and pathogenesis of prion diseases Am J Pathol 146 1995 785
26. R.Y. Dodd Adverse consequences of blood transfusion: Quantitative risk estimates S.T. Nance Blood Supply Risks, Perceptions and Prospects for the Future 1994 American Association of Blood Banks Bethesda 1
27. R.Y. Dodd Scaling the heights [editorial] Transfusion 35 1995 186
28. J.P. Dreslys C. Lasmezas D. Dormont Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease Lancet 343 1994 848
29. M.L. Eberhard E.M. Walker F.J. Steurer Survival and infectivity of Babesia in blood maintained at 25°C and 2–4°C J Parasitol 81 1995 790
30. T.F.G. Esmonde R.G. Will J.M. Slattery Creutzfeldt-Jakob disease and blood transfusion Lancet 341 1993 205
31. D. Gallo E.T. Yeh E.S. Moore Comparison of four enzyme immunoassays for detection of human T-cell lymphotropic virus type 2 antibodies J Clin Microbiol 34 1996 213
32. S.-J. Gao L. Kingsley M. Li KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma Nature Med 2 1996 925
33. M.A. Gerber E.D. Shapiro P.J. Krause The risk of acquiring Lyme disease or babesiosis from a blood transfusion J Infect Dis 170 1994 231
34. G.P. Giacoia D.O. Kasprisin Transfusion-acquired hepatitis A South Med J 82 1989 1357
35. D. Gretch Diagnostic tests for hepatitis C Program and Abstracts of NIH Consensus Development Conference on Management of Hepatitis C 1997 National Institutes of Health Bethesda 45
36. C.G. Hatalski A.J. Lewis W.I. Lipkin Borna disease Emerg Infect Dis 3 1997 129
37. N. Heye S. Hensen N. Muller Creutzfeldt-Jakob disease and blood transfusion Lancet 343 1994 298
38. B.L. Herwaldt A.M. Kjemtrup P.A. Conrad Transfusion-transmitted babesiosis in Washington state: First reported case caused by a WA1-type parasite J Infect Dis 175 1997 1259
39. B. Hjelle C. Wilson S. Cyrus Human T-cell leukemia virus type II infection frequently goes undetected in contemporary U.S. blood donors Blood 81 1993 1641
40. R.C. Holman A.S. Khan E.D. Belay Creutzfeldt-Jakob disease in the United States, 1979–1994: Using national mortality data to assess the possible occurrence of variant cases Emerg Infectious Dis 2 1996 333
41. P.A. Hoppe Interim measures for detection of bacterially contaminated red cell components [editorial] Transfusion 32 1992 199
42. D.J. Hu T.J. Dondero M.A. Rayfield The emerging genetic diversity of HIV: The importance of global surveillance for diagnostics, research, and prevention JAMA 275 1996 210
43. M.-A. Kedda M.C. Kew R.J. Cohn An outbreak of hepatitis A among South African patients with hemophilia: Evidence implicating contaminated factor VIII concentrate as the source Hepatology 22 1995 1363
44. D.H. Kedes E. Operskalski M. Busch The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission Nature Med 2 1996 918
45. R.F. Khabbaz W. Heneine J.E. Kaplan Testing for other human retroviruses: HTLV-I and HTLV-II G. Schochetman J.R. George AIDS Testing ed 2 1994 Springer-Verlag New York 206
46. K. Kondo Y. Kuroiwa A case control study of Creutzfeldt-Jakob disease: Association with physical injuries Ann Neurol 11 1982 377
47. R.L. Koretz G.L. Gitnick Prevention of post-transfusion hepatitis: Role of sensitive hepatitis B antigen screening tests, source of blood and volume of transfusion Am J Med 59 1975 754
48. B.L. Kroner P.S. Rosenberg L.M. Aledort HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978–1990 J Acquir Immune Defic Syndr 7 1994 279
49. E.M. Lackritz G.A. Satten J. Aberle-Grasse Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States N Engl J Med 333 1995 1721
50. Lackritz EM, Stramer SL, Jacobs TA, et al: Results of national testing of U.S. blood donations for HIV-1 p24 antigen [abstract 751]. In Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington DC, 1997, p 203
51. D.A. Leiby E.J. Read B.A. Lenes Seroepidemiology of Trypanosoma cruzi , etiologic agent of Chagas' disease, in U.S. blood donors J Infect Dis 176 1997 1047
52. E. Lennette D.J. Blackbourn J.A. Levy Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients Lancet 348 1996 858
53. B.W. Little J. Mastrianni A.L. DeHaven The epidemiology of Creutzfeldt-Jakob disease in eastern Pennsylvania [abstract] Neurology 43 1993 A316
54. N.L.C. Luban Human parvoviruses: Implications for transfusion medicine Transfusion 34 1994 821
55. P.M. Mannucci Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates Vox Sang 64 1993 197
56. P.M. Mannucci S. Gdovin A. Gringeri Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses Ann Intern Med 120 1994 1
57. E.E. Manuelidis J.H. Kim J.R. Mericangas Transmission to animals of Creutzfeldt-Jakob disease from human blood Lancet 2 1985 896
58. E.D. Mintz J.F. Anderson R.G. Cable Transfusion-transmitted babesiosis: A case report from a new endemic area Transfusion 31 1991 365
59. J.F. Morrow H.G. Braine T.S. Kickler Septic reactions to platelet transfusions: A persistent problem JAMA 266 1991 555
60. K.E. Nelson J.G. Donahue A. Munoz Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery: A multicenter study of HIV-1 and HTLV-I/II infections Ann Intern Med 117 1992 554
61. T.R. O'Brien J.R. George S.D. Holmberg Human immunodeficiency virus type 2 infection in the United States: Epidemiology, diagnosis, and public health implications JAMA 267 1992 2775
62. E.A. Operskalski D.H. Kedes D. Ganem A study of the potential transmissibility by transfusion of Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8) [abstract S225] Transfusion 36S 1996 57S
63. M.V. Ragni W.C. Koch J.A. Jordan Parvovirus B19 infection in patients with hemophilia Transfusion 36 1996 238
64. C.P. Pau D.J. Hu C. Spruill Surveillance for human immunodeficiency virus type 1 group O infections in the United States Transfusion 36 1996 398
65. M.A. Popovsky Transfusion-transmitted babesiosis Transfusion 31 1991 296
66. C. Schable L. Zekeng C.P. Pau Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections Lancet 344 1994 1333
67. Schonberger LB, Sullivan M, Holman RC, et al: Creutzfeldt-Jakob disease (CJD) and blood safety. In Program for Xth International Congress of Virology, Jerusalem, 1996, p 211
68. G.A. Schmunis Trypanosoma cruzi , the etiologic agent of Chagas' disease: Status in the blood supply in endemic and nonendemic countries Transfusion 31 1991 547
69. G.B. Schreiber M.P. Busch S.H. Kleinman The risk of transfusion-transmitted viral infections N Engl J Med 334 1996 1685
70. I.A. Schulman M.D. Appleman S. Saxena Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California Transfusion 37 1997 727
71. R.M. Selik J.W. Ward J.W. Buehler Trends in transfusion-associated acquired immune deficiency syndrome in the United States, 1982 through 1991 Transfusion 33 1993 890
72. E.M. Sloand E. Pitt H.G. Klein Safety of the blood supply JAMA 274 1995 1368
73. Soucie JM, Robertson BH, Bell BP, et al: Hepatitis A virus infections associated with clotting factor concentrate in the United States, submitted to Transfusion
74. M. Sullivan A. Williams E. Guido Detection and characterization of an HIV type 2 antibody positive blood donor in the U.S. [abstract] Transfusion 37S 1997 58S
75. P.S. Sullivan A.N. Do K. Robbins Surveillance for variant strains of HIV: Subtype G and group O HIV-1 [letter] JAMA 278 1997 292
76. Y. Tamai H. Kojima R. Kitajima Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease N Engl J Med 327 1992 649
77. J. Tateishi Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice Lancet 2 1985 1074
78. M.A. Tipple L.A. Bland J.J. Murphy Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica Transfusion 30 1990 207
79. T.J. Torok Human parvovirus B19 J.S. Remington J.O. Klein Infectious Diseases of the Fetus and Newborn Infant 1995 WB Saunders Philadelphia
80. U.S. General Accounting Office Blood supply: Transfusion-associated risks 1997 Government Printing Office Washington, DC GAO/PEMD-97-a
81. S.J. Wagner L.I. Friedman R.Y. Dodd Transfusion-associated bacterial sepsis Clin Microbiol Rev 7 1994 290
82. G.M. Wells T.E. Woodward P. Fiset Rocky Mountain spotted fever caused by blood transfusion JAMA 239 1978 2763
83. A.E. Williams R.A. Thomson G.B. Schreiber Estimates of infectious disease risk factors in US blood donors JAMA 277 1997 967
84. M.D. Williams B.J. Cohen A.C. Beddall Transmission of human parvovirus B19 by coagulation factor concentrates Vox Sang 58 1990 177